Via Mercola
Story at-a-glance
- According to research published in December 2023, the mRNA COVID shots suffer high rates of ribosomal “frameshifting,” which causes your cells to produce off-target proteins that can trigger unintended immune reactions
- According to the authors, off-target cellular immune responses occur in 25% to 30% of people who have received the COVID shot
- The U.S. Food and Drug Administration and Australia’s Therapeutic Goods Administration are refusing to release the RNA stability data they supposedly relied on when approving a change to Pfizer’s shot that allowed it to be transported and stored at temperatures of -20 degrees Celsius instead of -70 C
- The FDA also authorized Pfizer to swap the phosphate-buffered saline buffer used in the adult formulations, to a tromethamine (Tris) buffer in the children’s version. FDA did not require any kind of testing to be conducted, and no data have been released in support of its decision to allow the swap
- According to research published in 2023, the nanolipid in Comirnaty, made by Pfizer/BioNTech, is toxic to cells and triggers proinflammatory cytokines and reactive oxygen species that can disrupt the mitochondrial membrane causing it to release its content, cause RNA mistranslation, DNA mutations, destruction of the nuclear membrane and more. Frequent repetitions of COVID boosters and/or using mRNA in other vaccines poses a grave public health risk, the scientist warns
According to research published in the December 6, 2023, issue of Nature, the mRNA COVID shots suffer from high rates of ribosomal “frameshifting,” which causes your cells to produce off-target proteins with unknown effects.1,2,3 As explained in that paper:4
Continue reading “New Safety Concerns About the COVID Shots Arise”
